Bennet et al. found that individuals with KILLIN-promoter methylation had a threefold increased prevalence of breast cancer over phosphatase and tension homologue on chromosome 10 (PTEN) mutation-positive individuals [10]. The gene discussed is KLLN; the disease is breast cancer.